Annovis Bio Inc

Market cap: $122,115,306

Exchange: NYS

Sector: Health Technology

Share
Tweet

Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.

Key Statistics

Company Name

Annovis Bio Inc

Average Volume (10 days)

139,002

Average Volume (30 days)

291,082

Moving Average (50 days)

$10.34

Moving Average (200 days)

$9.99

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

122,115,306

Shares Outstanding

11,011,299

52-Week High Split Adjust Only

22.49

52-Week Low Split Adjust Only

5.42

Employee Count

8

Beta

0

Next Earnings Date

2024-05-09

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

-0.03%

Past 30 days

0.22%

Past 3 months

-0.14%

Past 6 months

0.41%

Past year

-0.26%

Past 2 years

-0.16%

Past 5 years

0.16%

Max % Change

0.16%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Annovis Bio IncANVSn/an/an/an/an/a
Peer AvgN/A3.912.9510.53.913.73
Arista Networks IncANET10.787.67n/a10.789.54
Itron Inc.ITRI2.053.6038.82.052.21
Diebold Nixdorf IncDBD0.27-1.256.60.270.78
Seachange International Inc.SEAC2.551.78-3.52.552.38